Trinity Biotech (TRIB) has released an update.
Trinity Biotech plc, an Irish public limited company, has announced the offer and sale of American Depositary Shares (ADSs) amounting to over $1 million through a prospectus supplement to their existing registration statement. This move, part of an at-the-market offering agreement, has been validated by legal counsel, ensuring the company’s good standing under Irish law and the legitimacy of the shares issuance. Investors are kept in the loop as Trinity Biotech continues to navigate the financial landscape with this latest strategic financial move.
For further insights into TRIB stock, check out TipRanks’ Stock Analysis page.
